ArticlebioRxiv : the preprint server for biology2024

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy.

Or-Yam Revach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.